Metastat Insights
Pharmaceutical Excipientsexcipients marketdrug formulation

Top 30 Companies Global Pharmaceutical Excipients Market in (2025-2033): Metastat Insights Analysis

August 27, 2026ByMetastat Insights Research Team

Explore the top 30 Pharmaceutical Excipients companies driving innovation and growth in the Global Pharmaceutical Excipients Market from 2025 to 2033.

The Global Pharmaceutical Excipients Market is valued at USD 10.7 Billion in 2025 and is projected to reach USD 15.1 Billion by 2033, growing at a CAGR of 4.4%. This market encompasses various excipients used in drug formulations, including fillers, binding agents, and lubricants, crucial for the manufacturing of pharmaceuticals. Factors such as increasing demand for advanced drug delivery systems and the growth of the biopharmaceutical sector are driving market expansion.

Several companies contribute significantly to this market, providing a range of excipients that enhance drug performance and stability. The growth trajectory reflects the increasing complexity of drug formulations, necessitating innovative excipient solutions to meet evolving pharmaceutical requirements.

Top 30 Companies Global Pharmaceutical Excipients Market in (2025-2033): Metastat Insights Analysis

Global Pharmaceutical Excipients Market Size, Data, & Statistics

The Global Pharmaceutical Excipients Market was valued at USD 9.1 Billion in 2021. It increased to USD 9.4 Billion in 2022 and further to USD 9.9 Billion in 2023. By 2024, the market size is expected to reach USD 10.2 Billion.

In 2025, the market is projected to attain a size of USD 10.7 Billion, continuing its upward trend. The forecast for 2033 indicates a significant escalation to USD 15.1 Billion. The compound annual growth rate (CAGR) from 2025 to 2033 is estimated at 4.4%.

Yearly series data demonstrates consistent growth, with estimates showing USD 11.2 Billion in 2026, USD 11.7 Billion in 2027, and USD 12.2 Billion in 2028. By 2029, the market is anticipated to reach USD 12.7 Billion, progressing to USD 13.3 Billion in 2030 and USD 13.9 Billion in 2031.

The regional distribution of the market showcases North America leading with 34.3%, followed by Asia Pacific at 28.9%, and Europe at 27.8%. South America accounts for 4.7%, while the Middle East and Africa hold 4.3% of the market share.

Top 10 Trends in the Global Pharmaceutical Excipients Market

Inline metrology moves onto the production line

Inline metrology technology is increasingly integrated into pharmaceutical production processes. This advancement allows for real-time quality control, ensuring that excipients meet stringent specifications as they are produced. Buyers can expect improved consistency and reduced waste, leading to more efficient production operations.

Sustainability drives raw material innovation

The push for sustainability influences the sourcing of excipients, with companies exploring renewable and biodegradable materials. This trend supports the reduction of environmental impact and aligns with regulatory pressure for greener manufacturing processes. Buyers will benefit from enhanced brand reputation and compliance with environmental standards.

Growth of biopharmaceuticals increases demand

The biopharmaceutical sector's growth accelerates the need for specialized excipients tailored for biologics. These excipients are crucial for stability and delivery of complex molecules such as proteins and monoclonal antibodies. Buyers need to consider sourcing from suppliers with expertise in biopharmaceutical excipients to meet evolving formulation requirements.

Technological advancements in excipient formulations

Innovations in excipient formulations, including functional excipients, are transforming the market. These advancements enhance drug solubility, bioavailability, and overall effectiveness. Buyers should seek suppliers that invest in R&D to access innovative solutions that can improve product performance.

Regulatory pressures shape excipient selection

Increased scrutiny from regulatory bodies necessitates rigorous testing and validation of excipients. Suppliers must ensure compliance with stringent guidelines, which influences buyer decisions. A strong focus on regulatory adherence can enhance product credibility and market access.

Demand for personalized medicine influences excipient development

The rise of personalized medicine necessitates adaptable excipients capable of supporting individualized therapies. Suppliers are responding by developing versatile excipients that can be tailored to specific patient needs. Buyers should prioritize partnerships with companies that offer flexible and innovative excipient solutions.

Digitalization improves supply chain efficiency

Digital transformation initiatives are enhancing the efficiency of supply chains across the pharmaceutical sector. By leveraging data analytics and automation, companies can streamline operations, reduce lead times, and optimize inventory management. Buyers benefit from more reliable supply chains and improved service levels.

Focus on advanced drug delivery systems

The demand for advanced drug delivery systems, such as nanoparticles and implantable devices, shapes excipient development. These systems require specialized excipients to enhance delivery and release profiles. Buyers should engage with suppliers that have expertise in advanced formulation technologies to meet these emerging needs.

Emergence of multifunctional excipients

Multifunctional excipients are gaining traction as they serve multiple roles within formulations, reducing the number of components needed. This trend simplifies formulation development and manufacturing processes. Buyers should look for suppliers that offer these innovative excipient solutions to enhance formulation efficiency.

Increased collaboration across the supply chain

Collaboration between excipient manufacturers and pharmaceutical companies is increasingly important for successful product development. This cooperative approach facilitates knowledge sharing and innovation. Buyers should seek partners that prioritize collaboration to drive mutual success in the dynamic pharmaceutical landscape.

Top 30 Companies in the Global Pharmaceutical Excipients Market

1. ABITEC Corporation

Founded: 1989

ABITEC Corporation specializes in manufacturing excipients and components for the pharmaceutical and nutritional industries. The company offers a diverse range of lipid-based excipients, including monoglycerides and diglycerides, which enhance drug solubility and absorption. ABITEC's commitment to quality and innovation positions it as a reliable partner for pharmaceutical formulators.

2. Air Liquide SA

Founded: 1902

Air Liquide SA provides gases and related services for various industries, including pharmaceuticals. The company supplies excipients used in drug formulation, focusing on high-purity gases and innovative packaging solutions. Air Liquide's expertise in gas technologies enhances the efficiency and safety of pharmaceutical manufacturing processes.

3. Archer Daniels Midland Company

Founded: 1902

Archer Daniels Midland Company is a global leader in agricultural processing, producing a wide range of food and pharmaceutical ingredients. Within the pharmaceutical sector, the company offers excipients derived from natural sources, such as starches and proteins, that meet diverse formulation requirements. Archer Daniels Midland's focus on sustainability and innovation supports the growing demand for clean label products.

4. Ashland Global Holdings Inc

Founded: 1924

Ashland Global Holdings Inc manufactures specialty chemicals and excipients for the pharmaceutical industry. The company's portfolio includes film-forming agents, binders, and other functional excipients that enhance drug stability and performance. Ashland's commitment to research and development ensures that it remains a trusted name in excipient innovation.

5. Associated British Foods

Founded: 1935

Associated British Foods operates across multiple sectors, including food and pharmaceuticals. The company supplies a variety of excipients that serve as functional ingredients in pharmaceutical formulations. Associated British Foods emphasizes quality and sustainability in its excipient offerings, helping customers achieve regulatory compliance and product effectiveness.

6. Avantor, Inc.

Founded: 1904

Avantor, Inc. is a global provider of mission-critical products and services for the biopharma, healthcare, and education industries. The company offers a comprehensive range of excipients, including cell culture media and other specialty ingredients for pharmaceutical applications. Avantor's focus on customer collaboration and innovation drives its success in the excipients market.

7. BASF SE

Founded: 1865

BASF SE is one of the world's largest chemical producers, offering a diverse portfolio of excipients for the pharmaceutical industry. The company develops excipients that improve drug formulation performance and bioavailability. BASF's investment in research and development enables it to provide innovative solutions that meet the evolving needs of pharmaceutical formulators.

8. Clariant AG

Founded: 1995

Clariant AG specializes in specialty chemicals and offers a wide range of excipients for pharmaceutical applications. The company focuses on developing innovative solutions that enhance drug delivery and stability. Clariant's commitment to sustainability and responsible care is reflected in its excipient offerings, supporting customer needs for environmentally friendly products.

9. Colorcon, Inc.

Founded: 1961

Colorcon, Inc. is a global leader in the development of excipients and coatings for the pharmaceutical industry. The company provides a comprehensive range of solutions that improve the appearance, performance, and stability of pharmaceutical products. Colorcon's focus on innovation and customer collaboration ensures that it meets the changing demands of the market.

10. Croda International Plc

Founded: 1925

Croda International Plc specializes in the manufacture of specialty chemicals and excipients for various industries, including pharmaceuticals. The company offers a wide range of excipients that enhance drug performance and formulation stability. Croda's commitment to sustainability and innovation underpins its strategy in the excipients market.

11. DFE Pharma GmbH & Co KG

Founded: 2000

DFE Pharma GmbH & Co KG focuses on producing excipients specifically for the pharmaceutical industry. The company offers a comprehensive portfolio of excipients, including lactose-based products and other functional ingredients that enhance drug formulation. DFE Pharma's dedication to quality and innovation positions it as a trusted partner in the pharmaceutical excipients sector.

12. Dow Inc

Founded: 1897

Dow Inc is a global chemical company that supplies a variety of materials, including excipients for pharmaceuticals. The company focuses on providing innovative solutions that meet the needs of formulators in the pharmaceutical sector. Dow's commitment to sustainability and customer collaboration drives its success in the excipients market.

13. DuPont de Nemours Inc

Founded: 1802

DuPont de Nemours Inc is a diversified science and technology company that provides a range of products, including excipients for the pharmaceutical industry. The company's excipient offerings include various functional ingredients that support drug formulation and performance. DuPont's focus on innovation and sustainability positions it well in the evolving pharmaceutical landscape.

14. Eastman Chemical Company

Founded: 1920

Eastman Chemical Company manufactures a variety of specialty chemicals and excipients for the pharmaceutical sector. The company focuses on providing innovative solutions that enhance drug formulation and delivery. Eastman's commitment to quality and customer service ensures its excipients meet the rigorous standards of the pharmaceutical industry.

15. Evonik Industries AG

Founded: 2007

Evonik Industries AG is a global leader in specialty chemicals, offering a range of excipients for pharmaceuticals. The company develops innovative solutions that improve drug delivery and performance. Evonik's emphasis on sustainability and research and development supports its position in the pharmaceutical excipients market.

16. Fuji Chemical Industries Co., Ltd.

Founded: 1950

Fuji Chemical Industries Co., Ltd. specializes in the production of excipients and pharmaceutical ingredients. The company offers a range of products that enhance drug solubility and bioavailability. Fuji's commitment to quality and innovation has made it a key player in the global pharmaceutical excipients market.

17. Gattefossé

Founded: 1880

Gattefossé is renowned for its expertise in lipid-based excipients for pharmaceutical applications. The company develops specialized excipients that improve drug formulation and delivery. Gattefossé's focus on innovation and customer collaboration positions it as a trusted partner for pharmaceutical formulators.

18. Innophos Holdings Inc

Founded: 2009

Innophos Holdings Inc provides specialty phosphate-based excipients for the pharmaceutical industry. The company focuses on delivering innovative solutions that enhance drug stability and performance. Innophos' commitment to quality and customer satisfaction drives its success in the pharmaceutical excipients market.

19. International Flavors & Fragrances

Founded: 1833

International Flavors & Fragrances is a leading company in the flavor and fragrance industry, offering excipients for pharmaceuticals as well. The company supplies a variety of excipients that enhance product performance. IFF's commitment to sustainability and innovation drives its product development in the pharmaceutical sector.

20. IOI Oleo GmbH

Founded: 1988

IOI Oleo GmbH specializes in the production of oleochemical products and excipients for the pharmaceutical industry. The company's offerings include specialty excipients that improve drug formulation and performance. IOI Oleo's focus on quality and innovation positions it as a key supplier in the pharmaceutical excipients market.

21. JRS Pharma GmbH & Co KG

Founded: 1878

JRS Pharma GmbH & Co KG specializes in the manufacture of excipients for the pharmaceutical and nutraceutical sectors. The company offers a range of cellulose-based excipients that enhance drug formulation and delivery. JRS Pharma's dedication to innovation and customer service drives its success in the excipients market.

22. Kerry Group plc

Founded: 1972

Kerry Group plc is a global leader in food and pharmaceutical ingredients, supplying a range of excipients for formulations. The company focuses on developing innovative solutions that meet the needs of formulators in the pharmaceutical sector. Kerry's commitment to sustainability and quality ensures its excipients meet rigorous industry standards.

23. Lipoid GmbH

Founded: 1984

Lipoid GmbH specializes in the production of phospholipids and other excipients for the pharmaceutical industry. The company's offerings are essential for drug formulation and delivery, particularly for liposomal products. Lipoid's dedication to quality and innovation positions it as a trusted partner for pharmaceutical companies.

24. Lubrizol Corporation

Founded: 1928

Lubrizol Corporation manufactures specialty chemicals and excipients for various industries, including pharmaceuticals. The company focuses on providing innovative solutions that enhance drug formulation and delivery. Lubrizol's commitment to quality and sustainability drives its success in the pharmaceutical excipients market.

25. MEGGLE GmbH & Co. KG

Founded: 1887

MEGGLE GmbH & Co. KG is a manufacturer of dairy products and excipients for the pharmaceutical industry. The company offers a range of lactose-based excipients that enhance drug formulation. MEGGLE's emphasis on quality and customer service positions it as a reliable supplier in the excipients market.

26. Merck KGaA

Founded: 1668

Merck KGaA is a global science and technology company that provides a variety of products, including excipients for pharmaceuticals. The company's excipient offerings support drug formulation and delivery, enhancing overall product performance. Merck's commitment to innovation and sustainability positions it well within the pharmaceutical excipients market.

27. NOF Corporation

Founded: 1932

NOF Corporation specializes in the manufacture of chemical products, including excipients for pharmaceuticals. The company provides a range of excipients that improve drug formulation and performance. NOF's dedication to quality and innovation drives its success in the pharmaceutical excipients market.

28. Novo Nordisk Pharmatech A/S

Founded: 1923

Novo Nordisk Pharmatech A/S focuses on producing excipients and raw materials for the pharmaceutical industry. The company offers a portfolio of high-quality excipients that enhance drug formulation and delivery. Novo Nordisk Pharmatech's commitment to sustainability and quality ensures it meets the needs of formulators in the pharmaceutical sector.

29. Pfanstiehl, Inc.

Founded: 1944

Pfanstiehl, Inc. specializes in the production of excipients and active pharmaceutical ingredients. The company offers a range of excipients that support drug formulation and delivery, focusing on quality and regulatory compliance. Pfanstiehl's expertise in excipient manufacturing positions it as a key player in the pharmaceutical excipients market.

30. Roquette Frères SA

Founded: 1933

Roquette Frères SA is a global leader in plant-based ingredients, offering a variety of excipients for the pharmaceutical industry. The company's product range includes starches and polyols that enhance drug formulation and performance. Roquette's commitment to innovation and sustainability positions it as a trusted partner for pharmaceutical formulators.

Conclusion

The Global Pharmaceutical Excipients Market is set for continued growth, driven by advancements in drug formulation technologies and increasing demand for personalized medicine. The emerging trends outlined indicate a robust focus on sustainability, innovation, and collaboration within the industry.

The presence of these 30 Pharmaceutical Excipients companies highlights the diverse range of solutions available to formulators. Engaging with these industry leaders allows buyers to leverage expertise and access innovative excipient solutions that meet the evolving requirements of the pharmaceutical landscape.

Tags

Pharmaceutical Excipientsexcipients marketdrug formulationpharmaceutical industrybiopharmaceuticals

About the Authors

UTKARSH KHIRODKAR

LEAD ANALYST

Utkarsh Khirodkar is a Lead Market Research Analyst at MetaStat Insight, specializing in market intelligence, technology sector assessments, and competitive strategy.

SNEHAL PASALKAR

SENIOR RESEARCH ANALYST

Biotechnology · Food and Beverages · Medical Devices · Packaging

Snehal Pasalkar is a Research Analyst at MetaStat Insight, operating at the intersection of life sciences research, competitive strategy, and market intelligence.